Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world’s leading provider of products and services for individuals with renal disease, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announce that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME’s wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S. By acquiring select laboratory assets from FME, Quest will add dialysis-related water testing, a new capability, to Quest’s comprehensive portfolio.
Read the full article: Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics //
Source: https://www.prnewswire.com/news-releases/fresenius-medical-care-announces-divestment-of-select-laboratory-assets-to-quest-diagnostics-302383348.html